Craig A Johnson

Craig A Johnson has an estimated net worth of $70.8 Million. This is based on reported shares across multiple companies, which include Odonate Therapeutics, Inc., Mirati Therapeutics, Inc., HERON THERAPEUTICS, INC. /DE/, PURE BIOSCIENCE, INC., LA JOLLA PHARMACEUTICAL CO, Adamis Pharmaceuticals Corp, NOVADEL PHARMA INC, TorreyPines Therapeutics, Inc., Ardea Biosciences, Inc./DE, and Aurinia Pharmaceuticals Inc..

2020 was Craig A Johnson's most active year for acquiring shares with 9 total transactions. Craig A Johnson's most active month to acquire stocks was the month of December. 2022 was Craig A Johnson's most active year for disposing of shares, totalling 12 transactions. Craig A Johnson's most active month to dispose stocks was the month of December. 2023 saw Craig A Johnson paying a total of $399,970.00 for 18,772 shares, this is the most they've acquired in one year. In 2020 Craig A Johnson cashed out on 30,000 shares for a total of $1,395,000.00, their largest year based on trade value.